sb 239063 has been researched along with Pneumonia in 1 studies
SB 239063: structure in first source
SB-239063 : A member of the class of imidazoles carrying 4-hydroxycyclohexyl, 4-fluorophenyl and 2-methoxypyrimidin-4-yl substituents at positions 1, 4 and 5 respectively.
Pneumonia: Infection of the lung often accompanied by inflammation.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Smith, SJ | 1 |
Fenwick, PS | 1 |
Nicholson, AG | 1 |
Kirschenbaum, F | 1 |
Finney-Hayward, TK | 1 |
Higgins, LS | 1 |
Giembycz, MA | 1 |
Barnes, PJ | 1 |
Donnelly, LE | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Regulation of the Release of Inflammatory Mediators From Lung Macrophages.[NCT00147017] | 17 participants (Actual) | Observational | 2001-06-30 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
(NCT00147017)
Timeframe: 20 hours
Intervention | ng/ml (Mean) |
---|---|
Smokers | 220.8 |
Ex-smokers | 251.2 |
Emphysema Lung Transplant | 167.8 |
GM-CSF, granulocyte macrophage-colony stimulating factor (NCT00147017)
Timeframe: 20 hours
Intervention | ng/ml (Mean) |
---|---|
Smokers | 2.2 |
Ex-smokers | 1.8 |
Emphysema Lung Transplant | 2.6 |
measure release of inflammatory mediators from isolated macrophages (NCT00147017)
Timeframe: 20 hours
Intervention | ng/ml (Mean) |
---|---|
Smokers | 6.1 |
Ex-smokers | 3.8 |
Emphysema Lung Transplant | 2.6 |
1 other study available for sb 239063 and Pneumonia
Article | Year |
---|---|
Inhibitory effect of p38 mitogen-activated protein kinase inhibitors on cytokine release from human macrophages.
Topics: Blotting, Western; Cells, Cultured; Cytokines; Dose-Response Relationship, Drug; Female; Granulocyte | 2006 |